Biomarker-directed, multi-drug, phase 1b trial in bladder cancer | Dr Hendrik-Tobias Arkenau at ECC 2015 - 101271

Spotlight
Video

Biomarker-directed, multi-drug, phase 1b trial in bladder cancer | Dr Hendrik-Tobias Arkenau at ECC 2015

EMJ has 458 videos Subscribe Here

Loading........
Description: At the European Cancer Congress (ECC) 2015, Hendrik-Tobias Arkenau, MD, PhD, of Sarah Cannon Research Institute UK, London, UK, discusses an open-label, biomarker-directed, multi-drug, multi-centre, multi-arm, randomised phase 1b clinical trial in patients with muscle-invasive urothelial carcinoma of the bladder who have progressed on prior treatment.

–––

European Medical Journal

Website: http://emjreviews.com/...
Twitter: https://twitter.com/EMJRevi...
Facebook: https://www.facebook.com/em...
Shared By : EMJ
Posted on : 10/17/15
Added : 2 years ago
Category : Bladder Cancer



Recommended

Nothing found.

More From EMJ

Nothing found.